355 related articles for article (PubMed ID: 32297954)
1. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics.
Krieger TG; Tirier SM; Park J; Jechow K; Eisemann T; Peterziel H; Angel P; Eils R; Conrad C
Neuro Oncol; 2020 Aug; 22(8):1138-1149. PubMed ID: 32297954
[TBL] [Abstract][Full Text] [Related]
2. Modeling Patient-Derived Glioblastoma with Cerebral Organoids.
Linkous A; Balamatsias D; Snuderl M; Edwards L; Miyaguchi K; Milner T; Reich B; Cohen-Gould L; Storaska A; Nakayama Y; Schenkein E; Singhania R; Cirigliano S; Magdeldin T; Lin Y; Nanjangud G; Chadalavada K; Pisapia D; Liston C; Fine HA
Cell Rep; 2019 Mar; 26(12):3203-3211.e5. PubMed ID: 30893594
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion.
da Silva B; Mathew RK; Polson ES; Williams J; Wurdak H
SLAS Discov; 2018 Sep; 23(8):862-868. PubMed ID: 29543559
[TBL] [Abstract][Full Text] [Related]
4. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids.
Pinto G; Saenz-de-Santa-Maria I; Chastagner P; Perthame E; Delmas C; Toulas C; Moyal-Jonathan-Cohen E; Brou C; Zurzolo C
Biochem J; 2021 Jan; 478(1):21-39. PubMed ID: 33245115
[TBL] [Abstract][Full Text] [Related]
6. Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion.
Darrigues E; Zhao EH; De Loose A; Lee MP; Borrelli MJ; Eoff RL; Galileo DS; Penthala NR; Crooks PA; Rodriguez A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639060
[TBL] [Abstract][Full Text] [Related]
7. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
[TBL] [Abstract][Full Text] [Related]
8. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
[TBL] [Abstract][Full Text] [Related]
9. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
[TBL] [Abstract][Full Text] [Related]
10. Modeling glioblastoma complexity with organoids for personalized treatments.
Pawlowski KD; Duffy JT; Babak MV; Balyasnikova IV
Trends Mol Med; 2023 Apr; 29(4):282-296. PubMed ID: 36805210
[TBL] [Abstract][Full Text] [Related]
11. Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasion.
Chen AT; Xiao Y; Tang X; Baqri M; Gao X; Reschke M; Sheu WC; Long G; Zhou Y; Deng G; Zhang S; Deng Y; Bai Z; Kim D; Huttner A; Kunes R; Günel M; Moliterno J; Saltzman WM; Fan R; Zhou J
Neuro Oncol; 2023 Mar; 25(3):482-494. PubMed ID: 35901838
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional model of glioblastoma by co-culturing tumor stem cells with human brain organoids.
Azzarelli R; Ori M; Philpott A; Simons BD
Biol Open; 2021 Feb; 10(2):. PubMed ID: 33619017
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma Model Using Human Cerebral Organoids.
Ogawa J; Pao GM; Shokhirev MN; Verma IM
Cell Rep; 2018 Apr; 23(4):1220-1229. PubMed ID: 29694897
[TBL] [Abstract][Full Text] [Related]
14. Development of glioblastoma organoids and their applications in personalized therapy.
Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
[TBL] [Abstract][Full Text] [Related]
15. Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion.
Cao MF; Chen L; Dang WQ; Zhang XC; Zhang X; Shi Y; Yao XH; Li Q; Zhu J; Lin Y; Liu S; Chen Q; Cui YH; Zhang X; Bian XW
Cancer Lett; 2019 Feb; 442():445-452. PubMed ID: 30472185
[TBL] [Abstract][Full Text] [Related]
16. Genetically engineered cerebral organoids model brain tumor formation.
Bian S; Repic M; Guo Z; Kavirayani A; Burkard T; Bagley JA; Krauditsch C; Knoblich JA
Nat Methods; 2018 Aug; 15(8):631-639. PubMed ID: 30038414
[TBL] [Abstract][Full Text] [Related]
17. O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.
Chahal M; Abdulkarim B; Xu Y; Guiot MC; Easaw JC; Stifani N; Sabri S
Mol Cancer Ther; 2012 Nov; 11(11):2440-50. PubMed ID: 22986464
[TBL] [Abstract][Full Text] [Related]
18. A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma.
Reed MR; Lyle AG; De Loose A; Maddukuri L; Learned K; Beale HC; Kephart ET; Cheney A; van den Bout A; Lee MP; Hundley KN; Smith AM; DesRochers TM; Vibat CRT; Gokden M; Salama S; Wardell CP; Eoff RL; Vaske OM; Rodriguez A
Cells; 2021 Dec; 10(12):. PubMed ID: 34943910
[TBL] [Abstract][Full Text] [Related]
19. The epidermal growth factor receptor variant type III mutation frequently found in gliomas induces astrogenesis in human cerebral organoids.
Kim HM; Lee SH; Lim J; Yoo J; Hwang DY
Cell Prolif; 2021 Feb; 54(2):e12965. PubMed ID: 33283409
[TBL] [Abstract][Full Text] [Related]
20. Single-cell RNA sequencing identifies critical transcription factors of tumor cell invasion induced by hypoxia microenvironment in glioblastoma.
Zhang Y; Zhang B; Lv C; Zhang N; Xing K; Wang Z; Lv R; Yu M; Xu C; Wang Y
Theranostics; 2023; 13(11):3744-3760. PubMed ID: 37441593
[No Abstract] [Full Text] [Related]
[Next] [New Search]
